Takeda and Biological E. Limited team up to provide Dengue Vaccine in endemic areas
Takeda and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, yesterday announced a strategic partnership to accelerate access to QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs). These doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest to support National Immunization Programs. […]
US FDA Permits Covid -19 Booster Dose From PFizer and BioNtech
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years […]
